Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases
Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases
About this item
Full title
Author / Creator
Publisher
Hoboken: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
Hoboken: Oxford University Press
Subjects
More information
Scope and Contents
Contents
ABSTRACT
Denosumab has been used successfully to treat disease‐associated osteoclast overactivity, including giant cell tumor of bone. Given its mechanism of action, denosumab is a potent potential treatment of other osteoclast bone dysplasias including central giant cell granuloma (CGCG), aneurysmal bone cyst (ABC), and cherubism. Relatively li...
Alternative Titles
Full title
Use of Denosumab in Children With Osteoclast Bone Dysplasias: Report of Three Cases
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_634a7574fa5949fca05f3da9a39ae284
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_634a7574fa5949fca05f3da9a39ae284
Other Identifiers
ISSN
2473-4039
E-ISSN
2473-4039
DOI
10.1002/jbm4.10210
